| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $2.41B | +17.9% |
| Cost of Revenue | $1.46B | +14.5% |
| Gross Profit | $943.9M | +23.6% |
| R&D Expense | $16.6M | -0.6% |
| SG&A Expense | $524.3M | +2.0% |
| Operating Income | $360.1M | +44.3% |
| Pre-tax Income | $380.9M | +41.8% |
| Income Tax | $93.0M | +44.2% |
| Net Income | $287.9M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $782.5M | +56.3% |
| Short-term Investments | $202.8M | +5.8% |
| Accounts Receivable | $559.6M | +18.4% |
| Inventory | $37.6M | +2.2% |
| Current Assets | $1.63B | +31.1% |
| Total Assets | $2.29B | +19.4% |
| Current Liabilities | $302.9M | +24.0% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $432.8M | +55.2% |
| Capital Expenditures | $1.8M | -21.5% |
| Investing Cash Flow | -$88.0M | +37.1% |
| Financing Cash Flow | -$62.9M | -28.1% |
| Free Cash Flow | $431.0M | +55.9% |
| +41.0% |
| EPS (Basic) | $6.69 | +39.7% |
| EPS (Diluted) | $5.95 | +26.9% |
| Long-term Debt |
| $416.3M |
| +0.4% |
| Total Liabilities | $814.3M | +9.4% |
| Stockholders' Equity | $1.48B | +25.8% |